In Treatment of Chronic obstructive pulmonary disease (COPD) Bronchodilators like VENTORLIN 2MG/5ML SYRUP help the airways in your lungs stay open. They work by relaxing the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.
It is not known whether it is safe to consume alcohol with VENTORLIN 2MG/5ML SYRUP. Please consult your doctor.
VENTORLIN 2MG/5ML SYRUP may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
VENTORLIN 2MG/5ML SYRUP is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
VENTORLIN 2MG/5ML SYRUP may cause side effects which could affect your ability to drive. VENTORLIN 2MG/5ML SYRUP may cause side effects such as dizziness, increased or uneven heart rate, muscle cramps or muscle pain. This may affect your ability to drive.
There is limited information available on the use of VENTORLIN 2MG/5ML SYRUP in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of VENTORLIN 2MG/5ML SYRUP in patients with liver disease. Please consult your doctor.
If you miss a dose of VENTORLIN 2MG/5ML SYRUP, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Labinduss Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ikon Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ultratech Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Standard Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lark Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: GRAF Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Roseate Medicare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Seagull Pharmaceutical Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Isis Pharmaceuticals || ₹14.5/tablet (25% cheaper)